POLLASTRI, SARA
POLLASTRI, SARA
Dipartimento di Scienze per gli Alimenti, la Nutrizione e l'Ambiente
Polyvalent Glycomimetic-Gold Nanoparticle Conjugates reveal effects of glycan display on Multivalent Lectin-Glycan Interactions
2024 X. Ning, D. Budhadev, S. Pollastri, I. Nehlmeier, A. Kempf, I. Manfield, B. Turnbull, S. Pöhlmann, A. Bernardi, X. Li, Y. Guo, D. Zhou
Development of a highly selective glycomimetic ligand for L-SIGN: a new tool against SARS-CoV-2 and Ebola viruses
2023 C. Delaunay, S. Pollastri, M. Thépaut, G. Cavazzoli, L. Belvisi, C. Bouchikri, N. Labiod, A. Gimeno, A. Franconetti, J. Jiménez-Barbero, A. Ardá, R. Delgado, A. Bernardi, F. Fieschi
SELECTIVE GLYCOMIMETIC LIGANDS OF C-TYPE LECTIN RECEPTORS
2023 S. Pollastri
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin
2022 D. Caracciolo, G. Juli, C. Riillo, A. Coricello, F. Vasile, S. Pollastri, R. Rocca, F. Scionti, N. Polerà, K. Grillone, M. Arbitrio, N. Staropoli, B. Caparello, D. Britti, G. Loprete, G. Costa, M.T. Di Martino, S. Alcaro, P. Tagliaferri, P. Tassone
Glycomimetic ligands block the interaction of SARS-CoV-2 spike protein with C-type lectin co-receptors
2022 S. Pollastri, C. Delaunay, M. Thepaut, F. Fieschi, A. Bernardi
Man-based glycomimetics inhibit DC/L-SIGN interaction with SARS-CoV-2 spike protein
2022 S. Pollastri, C. Delaunay, M. Thépaut, F. Fieschi, A. Bernardi
C2-Triazole-modified mannose-based L-SIGN antagonists
2022 S. Pollastri, C. Delaunay, M. Thépaut, F. Fieschi, A. Bernardi
Structural simplification of ps-diMan based glycomimetics as DC-SIGN antagonists
2021 S. Pollastri, C. Delaunay, C. Vivès, M. Thépaut, F. Fieschi, A. Bernardi